The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the False Claims Act (FCA) by causing the submission of false claims for the transmucosal immediate-release fentanyl (TIRF) Read More
Home » Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Related Posts
CEO of Georgia Company Convicted in International Bribery and Money
A federal jury in Miami, Florida, convicted a U.S. businessman today for his role in a nearly five-year long scheme to bribe Honduran government officials… BronCEO of Georgia Company Convicted in International Bribery and Money
Nigerian National Sentenced to Prison for International Scheme that Defrauded Elderly U.S. Victims
A Nigerian national was sentenced to 97 months in prison for his role in a transnational inheritance fraud scheme. Read More
Former Defense Contractor Sentenced to Over 10 Years in Prison for
John Murray Rowe Jr., 67, of Lead, South Dakota, was sentenced today to 126 months in prison followed by three years of supervised release and… BronFormer Defense Contractor Sentenced to Over 10 Years in Prison for